EPS Diluted (TTM) Chart

Historical EPS Diluted (TTM) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -2.173
March 31, 2026 -2.002
December 31, 2025 -1.737
September 30, 2025 -0.8103
June 30, 2025 -0.4897
March 31, 2025 -0.1627
December 31, 2024 0.0767
September 30, 2024 -0.5075
June 30, 2024 -0.4659
March 31, 2024 -0.5196
December 31, 2023 -0.5717
September 30, 2023 -0.2073
June 30, 2023 -0.2658
March 31, 2023 -0.2926
Date Value
December 31, 2022 -0.3725
September 30, 2022 -1.332
June 30, 2022 -1.765
March 31, 2022 -2.258
December 31, 2021 -2.562
September 30, 2021 -2.269
June 30, 2021 -1.868
March 31, 2021 -1.351
December 31, 2020 -0.968
September 30, 2020 -0.8017
June 30, 2020 -0.5563
March 31, 2020 -0.3704
December 31, 2019 -0.2108

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Capricor Therapeutics, Inc. -2.449
Sionna Therapeutics, Inc. -2.169
Nektar Therapeutics -6.697
Ardelyx, Inc. -0.2261
Kyntra Bio, Inc. 32.31